Effect of a nonpepf ide vasopressin v1 antagonist (OPC-21268) on experimental accelerated focal glomerulosclerosis

Nephron

Volumn 73, Issue 4, 1996, Pages 629-636

  Kurihara, Isao ^a   Saito, Takao ^a   Ohara, Katsuya ^a   Shoji, Yoshiharu ^a   Hirai, Mariko ^a   Soma, Jun ^a   Sato, Hiroshi ^a   Imai, Yutaka ^a   Abe, Keishi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Focal glomerulosclerosis; Spontaneously hypercholesterolemic rat; Triglyceride; Vasopressin V1 antagonist

Indexed keywords

1 [1 [4 (3 ACETAMIDOPROPOXY)BENZOYL] 4 PIPERIDYL] 1,2,3,4 TETRAHYDRO 2 QUINOLINONE; CREATININE; TRIACYLGLYCEROL; UREA; VASOPRESSIN; VASOPRESSIN ANTAGONIST; VASOPRESSIN V1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS; HYPERCHOLESTEROLEMIA; KIDNEY INTERSTITIUM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; RAT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UNINEPHRECTOMY; UREA NITROGEN BLOOD LEVEL;

ANIMALS; BLOOD PRESSURE; BLOOD UREA NITROGEN; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HYPERCHOLESTEROLEMIA; KIDNEY; KIDNEY FUNCTION TESTS; LIPIDS; MALE; NEPHRECTOMY; PIPERIDINES; PROTEINURIA; QUINOLONES; RATS; RATS, INBRED STRAINS; RECEPTORS, VASOPRESSIN;

EID: 0029780468     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189151     Document Type: Article

References (32)

1. Korbet SM. Schwartz MM. Lewis EJ: Primary focal segmental glomerulosclerosis: Clinical course and response to therapy. Am J Kidney Dis 1994:23:773-783.
2. Schwartz MM. Korbet SM: Primary focal segmental glomerulosclerosis: Pathology, histological variants, and pathogenesis. Am J Kidney Dis 1993;22:874-883.
3. Pei Y, Cattran D, Delmore T. Katz A. Lang A. Ranee P: Evidence suggesting undcrtrcatmcnt in adults with idiopathic focal segmental glomerulosclerosis. Am J Med 1987;82:938-944.
4. Saito T, Ootaka T. Sato H. Furuta T. Sato T. Soma J. Abe K. Yoshinaga K: Participation of macrophages in segmental endocapillary proliferation preceding focal glomerular sclerosis. J Pathol 1993;170:179-185.
5. Smat Y. Matsumura H. Miyajima H. Oka K: Serum and tissue lipids and glomerulonephritis in the spontaneously hypereholesterolemic rat. With a note on the effects of gonadectomy. Atherosclerosis 1977;27:165-178.
6. Yoshikawa Y. Yamasaki K: Renal lesions of hyperlipidémie Imai rats: A spontaneous animal model of focal glomerulosclerosis. Nephron 1991:59:471-476.
7. Yamamura Y, Ogawa H, Chihara T. Kondo K, Onogawa T, Nakamura S. Mori T, Tominaga M. Yabuuchi Y: OPC-21268, an orally effective. nonpeptide vasopressin VI receptor antagonist. Science 1991,252:572-574.
8. Jard S. Lombard C, Marie J. Devilliers G: Vasopressin receptors from cultured mesangial cells resemble Via type. Am J Physiol 1987; 253:F41-F49.
9. Ausiello DA, Kreisberg JI. Roy C. Karnovskv M: Comraclion of cultured rat glomerular cells of apparent mcsangial origin after stimulation with angiotensin II and arginine vasopressin. J Clin Invest 1980;65:754-760.
10. Ganz MB. Pekar SK. Perfetto MC. Sterzel RB: Arginine vasopressin promotes growth of rat glomerular mcsangial cells in culture. Am J Physiol 1988:255:F898-F906.
11. Bonventre JV. Skorecki KL, Kreisberg JI. Cheung JY: Vasopressin increases cytosolic free calcium concentration in glomerular me-sangial cells. Am J Physiol 1986:251:F94-F102.
12. Wolf G: Vasoactive substances as regulators of renal growth. Exp Nephrol 1993;1:141-151.
13. Lowry OH. Rosebrough NF. Farr AI. Randall RJ: Protein measurement with the Folin phenol reagent. J BiolChem 1951:193:265-275.
14. Saito T. Sumithran E. Glasgow EF, Atkins RC: The enhancement of antinonucleoside nephrosis by the co-administration of protamine. Kidney int 1987:32:691-699.
15. Saito T. Sato H. Obara K. Yamakage K. Abe K. Yoshinaga K: Progression of experimental focal glomerulosclerosis in the spontaneously hypertensive rat. J Lab Clin Med 1990:115:165-173.
16. Bennett WN. Walker RG. Kincaid-Smith P: Renal cortical interstitial volume in mcsangial IgA nephropathy. Dissociation from creatinine clearance in serially biopsicd patients. Lab Invest 1982;47:330-335.
17. Van Damme B. Koudstaal J: Measuring glomerular diameters in tissue sections. Virchows Arch [A] 1976:369:283-291.
18. Wang YX, Franco R. Gavras I, Gavras H: Effects of chronic administration of a vasopressin antagonist with combined antivasopressor and antiantidiuretic activities in rats with left ventricular dysfunction. J Lab Clin Med 1991: 117:313-318.
19. Yarnada Y, Yamamura Y. Chihara T. Onoga-wa T. Nakamura S. Yamashita T, Mori T. Tontinaga M. Yabuuehi Y: OPC-21268. A vasopressin VI antagonist, produces hypotension in spontaneously hypertensive rats. Hypertension 1994;23:200-204.
20. Burrell LM. Phillips PA, Stephenson JM. Ris-vanis J. Rolls KA. Johnston CI: Blood pressure-lowering effect of an orally active vasopressin VI receptor antagonist in mineralocorticoid hypertension in the rat. Hypertension 1994:23: 737-743.
21. Brooks DP. Sollcvcld HA. Contino LC: Vasopressin and the pathogenesis of chronic renal failure. Br J Pharmacol 1990:100:79-82.
22. Schor N, Ichikawa I. Brenner BM: Mechanisms of action of various hormones and vasoactive substances on glomerular ultrafiltration in the rat. Kidney Int 1981;20:442-451.
23. Wolthuis A. Boes A. Rodemann HP. Grond J: Vasoactive agents affect growth and protein synthesis of cultured rat mcsangial cells. Kidney Int 1992:41:124-131.
24. Floege J. Johnson RJ. Gordon K. lida H. Pritzl P. Yoshimura A. Campbell C, Alpers CE, Couser WG: Increased synthesis of extracellular matrix in mcsangial proliferative nephritis. Kidney Int 1991:40:477-488.
25. Nakamura T. Fukui M. Ebihara I. Tomino Y. Koide H: Low protein diet blunts the rise in glomerular gene expression in focal glomerulosclerosis. Kidney lnl 1994;45:1593-1605.
26. Dworkin LD. Grosser M. Feiner HD. Ullian M. Parker M: Renal vascular effects of antihypertensive therapy in uninephrectomized SHR. Kidney Int 1989:35:790-798.
27. Sakenti T. Baba N. Yoshikawa Y: Angiotensin-converting enzyme inhibition attenuates hypercholesterolemia and glomerular injury in hyperlipidemic Itnai rats. Nephron 1992:62: 315-321.
28. Sakerri T. Baba N: Effects of angiotensin II receptor antagonist on the progression of renal failure in hyperlipidemic Imai rats. Nephron 1993;65:426-432.
29. Risdon RA. Sloper JC: Relationship between renal function and histological changes found in rcnal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 1968:ii: 363-366.
30. Schainuck LI. Striker GE. Cutler RE, Benditt EP: Structural-functional correlations in renal disease. 11. The correlations. Hum Pathol 1970: 1:631-641.
31. Jeannct FA. Denton RM. Jeanrenaud B: Stimulation of hepatic lipogenesis and acetyl-coen-zvme A carboxvlase by vasopressin. Biochent J 1981:198:485-490.
32. Rossi R. Scharrer E: Mechanisms of the effects of vasopressin on plasma levels of free fatty acids and triglyceride in pygmy goats. Comp Biochent Physiol [A] 1993;104:287-290.